Patent | Date |
---|
Methods of preparing a re-usable single cell and methods for analyzing the epigenome, transcriptome, and genome of a single cell Grant 11,401,544 - Tosato , et al. August 2, 2 | 2022-08-02 |
Receptor Tyrosine Kinase Inhibitors For Treatment Of Protein Kinase Modulation-responsive Disease Or Disorder App 20220194943 - Tosato; Giovanna ;   et al. | 2022-06-23 |
Methods Of Preparing A Re-usable Single Cell And Methods For Analyzing The Epigenome, Transcriptome, And Genome Of A Single Cell App 20200102604 - Tosato; Giovanna ;   et al. | 2020-04-02 |
Induced Internalization Of Surface Receptors App 20130243769 - Tosato; Giovanna ;   et al. | 2013-09-19 |
Induced internalization of surface receptors Grant 8,420,620 - Tosato , et al. April 16, 2 | 2013-04-16 |
Induced Internalization Of Surface Receptors App 20100297124 - Tosato; Giovanna ;   et al. | 2010-11-25 |
Vasostatin as marrow protectant Grant 7,812,117 - Tosato , et al. October 12, 2 | 2010-10-12 |
Vasostatin As Marrow Protectant App 20090149380 - Tosato; Giovanna ;   et al. | 2009-06-11 |
Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth Grant 7,488,711 - Tosato , et al. February 10, 2 | 2009-02-10 |
SPECIFIC BINDING AGENTS FOR KSHV vIL-6 THAT NEUTRALIZE A BIOLOGICAL ACTIVITY App 20080260687 - Aoki; Yoshiyasu ;   et al. | 2008-10-23 |
Vasostatin as marrow protectant Grant 7,432,236 - Tosato , et al. October 7, 2 | 2008-10-07 |
Specific binding agents for KSHV vIL-6 that neutralize a biological activity Grant 7,374,756 - Aoki , et al. May 20, 2 | 2008-05-20 |
Specific binding agents for KSHV vIL-6 That neutrallize a biological activity App 20070243162 - Aoki; Yoshiyasu ;   et al. | 2007-10-18 |
Specific binding agents for KSHV vIL-6 that neutralize a biological activity Grant 7,235,365 - Aoki , et al. June 26, 2 | 2007-06-26 |
Specific binding agents for KSHV vIL-6 that neutralize a biological activity App 20070015197 - Aoki; Yoshiyasu ;   et al. | 2007-01-18 |
Specific binding agents for KSHV vIL-6 that neutralize a biological activity Grant 7,108,981 - Aoki , et al. September 19, 2 | 2006-09-19 |
Specific binding agents for KSHV vIL-6 that neutralize a biological activity App 20060039927 - Aoki; Yoshiyasu ;   et al. | 2006-02-23 |
Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth App 20050208018 - Tosato, Giovanna ;   et al. | 2005-09-22 |
Specific binding agents for KSHV vIL-6 that neutralize a biological activity Grant 6,939,547 - Aoki , et al. September 6, 2 | 2005-09-06 |
Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth Grant 6,867,180 - Tosato , et al. March 15, 2 | 2005-03-15 |
Vasostatin as marrow protectant App 20030216299 - Tosato, Giovanna ;   et al. | 2003-11-20 |
Specific binding agents for kshv vil-6 that neutralize a biological activity App 20030211468 - Aoki, Yoshiyasu ;   et al. | 2003-11-13 |
Treatment of Kaposi's sarcoma with IL-12 App 20030190305 - Yarchoan, Robert ;   et al. | 2003-10-09 |
Vasostatin as marrow protectant Grant 6,596,690 - Tosato , et al. July 22, 2 | 2003-07-22 |
Vasostatin as marrow protectant App 20030078198 - Tosato, Giovanna ;   et al. | 2003-04-24 |
Treatment of Kaposi's sarcoma with IL-12 Grant 6,509,321 - Yarchoan , et al. January 21, 2 | 2003-01-21 |
Treatment of Kaposi's sarcoma with IL-12 Grant 6,423,308 - Yarchoan , et al. July 23, 2 | 2002-07-23 |
Methods of inhibiting viral replication using IL-10 Grant 5,665,345 - Yarchoan , et al. September 9, 1 | 1997-09-09 |